Correlation Between Johnson Johnson and Intellia Therapeutics
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and Intellia Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and Intellia Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and Intellia Therapeutics, you can compare the effects of market volatilities on Johnson Johnson and Intellia Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of Intellia Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and Intellia Therapeutics.
Diversification Opportunities for Johnson Johnson and Intellia Therapeutics
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Johnson and Intellia is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and Intellia Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intellia Therapeutics and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with Intellia Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intellia Therapeutics has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and Intellia Therapeutics go up and down completely randomly.
Pair Corralation between Johnson Johnson and Intellia Therapeutics
Considering the 90-day investment horizon Johnson Johnson is expected to generate 0.18 times more return on investment than Intellia Therapeutics. However, Johnson Johnson is 5.57 times less risky than Intellia Therapeutics. It trades about -0.24 of its potential returns per unit of risk. Intellia Therapeutics is currently generating about -0.12 per unit of risk. If you would invest 16,160 in Johnson Johnson on August 27, 2024 and sell it today you would lose (643.00) from holding Johnson Johnson or give up 3.98% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Johnson Johnson vs. Intellia Therapeutics
Performance |
| Timeline |
| Johnson Johnson |
| Intellia Therapeutics |
Johnson Johnson and Intellia Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Johnson Johnson and Intellia Therapeutics
The main advantage of trading using opposite Johnson Johnson and Intellia Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, Intellia Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intellia Therapeutics will offset losses from the drop in Intellia Therapeutics' long position.| Johnson Johnson vs. Capricor Therapeutics | Johnson Johnson vs. Soleno Therapeutics | Johnson Johnson vs. Bio Path Holdings | Johnson Johnson vs. Moleculin Biotech |
| Intellia Therapeutics vs. Editas Medicine | Intellia Therapeutics vs. Caribou Biosciences | Intellia Therapeutics vs. Crispr Therapeutics AG | Intellia Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |